OverviewSuggest Edit

AZTherapies is a developer of pharmaceutical drugs designed to provide treatment for multiple neurodegenerations and neuroinflammation-related CNS diseases. Its product ALZT-OP1 is a novel multi-action combination drug regimen that is used to modify disease progression by slowing down or halting Alzheimer's disease early in its development.
HQBoston, US


AZTherapies is headquartered in
Boston, United States

Location Map

Latest Updates

Employees (est.) (Feb 2020)27(+13%)

AZTherapies Office Locations

AZTherapies has an office in Boston
Boston, US (HQ)
John Hancock Tower, 200 Clarendon St 17th Floor
Show all (1)

AZTherapies Financials and Metrics

Summary Metrics

Founding Date


AZTherapies total Funding

$64.1 m

AZTherapies latest funding size

$26.30 m

Time since last funding

4 months ago

AZTherapies investors

AZTherapies's latest funding round in October 2019 was reported to be $26.3 m. In total, AZTherapies has raised $64.1 m
Show all financial metrics

AZTherapies Online and Social Media Presence

Embed Graph

AZTherapies Frequently Asked Questions

  • When was AZTherapies founded?

    AZTherapies was founded in 2011.

  • How many employees does AZTherapies have?

    AZTherapies has 27 employees.

  • Who are AZTherapies competitors?

    Competitors of AZTherapies include Faes Farma, VenatoRx Pharmaceuticals and Blake Insomnia Therapeutics.

  • Where is AZTherapies headquarters?

    AZTherapies headquarters is located at John Hancock Tower, 200 Clarendon St 17th Floor, Boston.

  • Where are AZTherapies offices?

    AZTherapies has an office in Boston.

  • How many offices does AZTherapies have?

    AZTherapies has 1 office.